The global CROs Services market size was valued at US$ 74350 million in 2023. With growing demand in downstream market, the CROs Services is forecast to a readjusted size of US$ 144880 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global CROs Services market. CROs Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of CROs Services. Âé¶¹Ô´´ players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the CROs Services market.
Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities.
The contract research organizations (CRO) services market is experiencing significant growth due to various factors. Factors such as increasing outsourcing of clinical trials by pharmaceutical and biotechnology companies, rising demand for specialized services, and the need for cost-effective drug development are driving market expansion. CROs offer a wide range of services, including clinical trial management, data management, regulatory affairs, and pharmacovigilance, providing expertise and operational support to clients. Additionally, advancements in technology and the growing complexity of clinical research further contribute to market growth. Moreover, the global expansion of clinical trials and the rising focus on personalized medicine fuel the demand for CRO services. However, factors such as stringent regulatory requirements and challenges in data quality management may pose hurdles to market growth.
Key Features:
The report on CROs Services market reflects various aspects and provide valuable insights into the industry.
Âé¶¹Ô´´ Size and Growth: The research report provide an overview of the current size and growth of the CROs Services market. It may include historical data, market segmentation by Type (e.g., Full-Service CRO, Functional Service Provision CRO), and regional breakdowns.
Âé¶¹Ô´´ Drivers and Challenges: The report can identify and analyse the factors driving the growth of the CROs Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the CROs Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the CROs Services industry. This include advancements in CROs Services technology, CROs Services new entrants, CROs Services new investment, and other innovations that are shaping the future of CROs Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the CROs Services market. It includes factors influencing customer ' purchasing decisions, preferences for CROs Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the CROs Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting CROs Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the CROs Services market.
Âé¶¹Ô´´ Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the CROs Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the CROs Services market.
Âé¶¹Ô´´ Segmentation:
CROs Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Full-Service CRO
Functional Service Provision CRO
Segmentation by application
Pre-clinical
Clinical I-â…¢
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Charles River Laboratories International Inc (CRL)
Hangzhou Tigermed
Clinipace
PSI CRO
Pierrel Research
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Âé¶¹Ô´´ Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Âé¶¹Ô´´ Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Âé¶¹Ô´´ Estimation Caveats
2 Executive Summary
2.1 World Âé¶¹Ô´´ Overview
2.1.1 Global CROs Services Âé¶¹Ô´´ Size 2019-2030
2.1.2 CROs Services Âé¶¹Ô´´ Size CAGR by Region 2019 VS 2023 VS 2030
2.2 CROs Services Segment by Type
2.2.1 Full-Service CRO
2.2.2 Functional Service Provision CRO
2.3 CROs Services Âé¶¹Ô´´ Size by Type
2.3.1 CROs Services Âé¶¹Ô´´ Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CROs Services Âé¶¹Ô´´ Size Âé¶¹Ô´´ Share by Type (2019-2024)
2.4 CROs Services Segment by Application
2.4.1 Pre-clinical
2.4.2 Clinical I-â…¢
2.4.3 Other
2.5 CROs Services Âé¶¹Ô´´ Size by Application
2.5.1 CROs Services Âé¶¹Ô´´ Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CROs Services Âé¶¹Ô´´ Size Âé¶¹Ô´´ Share by Application (2019-2024)
3 CROs Services Âé¶¹Ô´´ Size by Player
3.1 CROs Services Âé¶¹Ô´´ Size Âé¶¹Ô´´ Share by Players
3.1.1 Global CROs Services Revenue by Players (2019-2024)
3.1.2 Global CROs Services Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global CROs Services Key Players Head office and Products Offered
3.3 Âé¶¹Ô´´ Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CROs Services by Regions
4.1 CROs Services Âé¶¹Ô´´ Size by Regions (2019-2024)
4.2 Americas CROs Services Âé¶¹Ô´´ Size Growth (2019-2024)
4.3 APAC CROs Services Âé¶¹Ô´´ Size Growth (2019-2024)
4.4 Europe CROs Services Âé¶¹Ô´´ Size Growth (2019-2024)
4.5 Middle East & Africa CROs Services Âé¶¹Ô´´ Size Growth (2019-2024)
5 Americas
5.1 Americas CROs Services Âé¶¹Ô´´ Size by Country (2019-2024)
5.2 Americas CROs Services Âé¶¹Ô´´ Size by Type (2019-2024)
5.3 Americas CROs Services Âé¶¹Ô´´ Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CROs Services Âé¶¹Ô´´ Size by Region (2019-2024)
6.2 APAC CROs Services Âé¶¹Ô´´ Size by Type (2019-2024)
6.3 APAC CROs Services Âé¶¹Ô´´ Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CROs Services by Country (2019-2024)
7.2 Europe CROs Services Âé¶¹Ô´´ Size by Type (2019-2024)
7.3 Europe CROs Services Âé¶¹Ô´´ Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CROs Services by Region (2019-2024)
8.2 Middle East & Africa CROs Services Âé¶¹Ô´´ Size by Type (2019-2024)
8.3 Middle East & Africa CROs Services Âé¶¹Ô´´ Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Âé¶¹Ô´´ Drivers, Challenges and Trends
9.1 Âé¶¹Ô´´ Drivers & Growth Opportunities
9.2 Âé¶¹Ô´´ Challenges & Risks
9.3 Industry Trends
10 Global CROs Services Âé¶¹Ô´´ Forecast
10.1 Global CROs Services Forecast by Regions (2025-2030)
10.1.1 Global CROs Services Forecast by Regions (2025-2030)
10.1.2 Americas CROs Services Forecast
10.1.3 APAC CROs Services Forecast
10.1.4 Europe CROs Services Forecast
10.1.5 Middle East & Africa CROs Services Forecast
10.2 Americas CROs Services Forecast by Country (2025-2030)
10.2.1 United States CROs Services Âé¶¹Ô´´ Forecast
10.2.2 Canada CROs Services Âé¶¹Ô´´ Forecast
10.2.3 Mexico CROs Services Âé¶¹Ô´´ Forecast
10.2.4 Brazil CROs Services Âé¶¹Ô´´ Forecast
10.3 APAC CROs Services Forecast by Region (2025-2030)
10.3.1 China CROs Services Âé¶¹Ô´´ Forecast
10.3.2 Japan CROs Services Âé¶¹Ô´´ Forecast
10.3.3 Korea CROs Services Âé¶¹Ô´´ Forecast
10.3.4 Southeast Asia CROs Services Âé¶¹Ô´´ Forecast
10.3.5 India CROs Services Âé¶¹Ô´´ Forecast
10.3.6 Australia CROs Services Âé¶¹Ô´´ Forecast
10.4 Europe CROs Services Forecast by Country (2025-2030)
10.4.1 Germany CROs Services Âé¶¹Ô´´ Forecast
10.4.2 France CROs Services Âé¶¹Ô´´ Forecast
10.4.3 UK CROs Services Âé¶¹Ô´´ Forecast
10.4.4 Italy CROs Services Âé¶¹Ô´´ Forecast
10.4.5 Russia CROs Services Âé¶¹Ô´´ Forecast
10.5 Middle East & Africa CROs Services Forecast by Region (2025-2030)
10.5.1 Egypt CROs Services Âé¶¹Ô´´ Forecast
10.5.2 South Africa CROs Services Âé¶¹Ô´´ Forecast
10.5.3 Israel CROs Services Âé¶¹Ô´´ Forecast
10.5.4 Turkey CROs Services Âé¶¹Ô´´ Forecast
10.5.5 GCC Countries CROs Services Âé¶¹Ô´´ Forecast
10.6 Global CROs Services Forecast by Type (2025-2030)
10.7 Global CROs Services Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 IQVIA
11.1.1 IQVIA Company Information
11.1.2 IQVIA CROs Services Product Offered
11.1.3 IQVIA CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.1.4 IQVIA Main Business Overview
11.1.5 IQVIA Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp CROs Services Product Offered
11.2.3 Labcorp CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 Syneos Health
11.3.1 Syneos Health Company Information
11.3.2 Syneos Health CROs Services Product Offered
11.3.3 Syneos Health CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.3.4 Syneos Health Main Business Overview
11.3.5 Syneos Health Latest Developments
11.4 PPD
11.4.1 PPD Company Information
11.4.2 PPD CROs Services Product Offered
11.4.3 PPD CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.4.4 PPD Main Business Overview
11.4.5 PPD Latest Developments
11.5 ICON
11.5.1 ICON Company Information
11.5.2 ICON CROs Services Product Offered
11.5.3 ICON CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.5.4 ICON Main Business Overview
11.5.5 ICON Latest Developments
11.6 PRA
11.6.1 PRA Company Information
11.6.2 PRA CROs Services Product Offered
11.6.3 PRA CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.6.4 PRA Main Business Overview
11.6.5 PRA Latest Developments
11.7 Parexel
11.7.1 Parexel Company Information
11.7.2 Parexel CROs Services Product Offered
11.7.3 Parexel CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.7.4 Parexel Main Business Overview
11.7.5 Parexel Latest Developments
11.8 Medpace
11.8.1 Medpace Company Information
11.8.2 Medpace CROs Services Product Offered
11.8.3 Medpace CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.8.4 Medpace Main Business Overview
11.8.5 Medpace Latest Developments
11.9 Wuxi Apptec
11.9.1 Wuxi Apptec Company Information
11.9.2 Wuxi Apptec CROs Services Product Offered
11.9.3 Wuxi Apptec CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.9.4 Wuxi Apptec Main Business Overview
11.9.5 Wuxi Apptec Latest Developments
11.10 EPS International
11.10.1 EPS International Company Information
11.10.2 EPS International CROs Services Product Offered
11.10.3 EPS International CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.10.4 EPS International Main Business Overview
11.10.5 EPS International Latest Developments
11.11 Worldwide Clinical Trials
11.11.1 Worldwide Clinical Trials Company Information
11.11.2 Worldwide Clinical Trials CROs Services Product Offered
11.11.3 Worldwide Clinical Trials CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.11.4 Worldwide Clinical Trials Main Business Overview
11.11.5 Worldwide Clinical Trials Latest Developments
11.12 CMIC
11.12.1 CMIC Company Information
11.12.2 CMIC CROs Services Product Offered
11.12.3 CMIC CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.12.4 CMIC Main Business Overview
11.12.5 CMIC Latest Developments
11.13 Premier Research
11.13.1 Premier Research Company Information
11.13.2 Premier Research CROs Services Product Offered
11.13.3 Premier Research CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.13.4 Premier Research Main Business Overview
11.13.5 Premier Research Latest Developments
11.14 Courante Oncology
11.14.1 Courante Oncology Company Information
11.14.2 Courante Oncology CROs Services Product Offered
11.14.3 Courante Oncology CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.14.4 Courante Oncology Main Business Overview
11.14.5 Courante Oncology Latest Developments
11.15 PROMETRIKA
11.15.1 PROMETRIKA Company Information
11.15.2 PROMETRIKA CROs Services Product Offered
11.15.3 PROMETRIKA CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.15.4 PROMETRIKA Main Business Overview
11.15.5 PROMETRIKA Latest Developments
11.16 Charles River Laboratories International Inc (CRL)
11.16.1 Charles River Laboratories International Inc (CRL) Company Information
11.16.2 Charles River Laboratories International Inc (CRL) CROs Services Product Offered
11.16.3 Charles River Laboratories International Inc (CRL) CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.16.4 Charles River Laboratories International Inc (CRL) Main Business Overview
11.16.5 Charles River Laboratories International Inc (CRL) Latest Developments
11.17 Hangzhou Tigermed
11.17.1 Hangzhou Tigermed Company Information
11.17.2 Hangzhou Tigermed CROs Services Product Offered
11.17.3 Hangzhou Tigermed CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.17.4 Hangzhou Tigermed Main Business Overview
11.17.5 Hangzhou Tigermed Latest Developments
11.18 Clinipace
11.18.1 Clinipace Company Information
11.18.2 Clinipace CROs Services Product Offered
11.18.3 Clinipace CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.18.4 Clinipace Main Business Overview
11.18.5 Clinipace Latest Developments
11.19 PSI CRO
11.19.1 PSI CRO Company Information
11.19.2 PSI CRO CROs Services Product Offered
11.19.3 PSI CRO CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.19.4 PSI CRO Main Business Overview
11.19.5 PSI CRO Latest Developments
11.20 Pierrel Research
11.20.1 Pierrel Research Company Information
11.20.2 Pierrel Research CROs Services Product Offered
11.20.3 Pierrel Research CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
11.20.4 Pierrel Research Main Business Overview
11.20.5 Pierrel Research Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.